Pure Biologics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.5%.

Top 14 shareholders own 36.21% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
7.75%	Filip Jelen	257,817	€473.4k	33.2%	no data
7.51%	Powszechna Kasa Oszczednosci Bank Polski Spólka Akcyjna	250,065	€459.2k	0%	no data
5.7%	Tadeusz Wesolowski	189,720	€348.4k	0%	no data
4.6%	Forum Towarzystwo Funduszy Inwestycyjnych S.A.	153,220	€281.3k	15.2%	0.14%
3.62%	Allianz Asset Management GmbH	120,630	€221.5k	-46.4%	no data
2.43%	Andrzej Trznadel	81,000	€148.7k	0%	no data
1.84%	Norges Bank Investment Management	61,080	€112.2k	12.8%	no data
0.79%	Andrzej Kierzkowski	26,221	€48.1k	0%	no data
0.59%	Maciej Mazurek	19,761	€36.3k	0%	no data
0.58%	Superfund Towarzystwo Funduszy Inwestycyjnych S.a.	19,295	€35.4k	0%	0.27%
0.34%	Piotr Jakimowicz	11,194	€20.6k	0%	no data
0.32%	BNPP Asset Management Holding	10,770	€19.8k	0%	no data
0.096%	Romuald Harwas	3,205	€5.9k	0%	no data
0.03%	Pieter Spee	1,000	€1.8k	0%	no data